UnknownPhase 2NCT02655198

Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy

Studying Epilepsy syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
KU Leuven
Principal Investigator
Lieven G Lagae, MD, PhD
Katolieke Universiteit Leuven, University Hospitals Gasthuisberg
Intervention
Fenfluramine(drug)
Enrollment
13 enrolled
Eligibility
3-18 years · All sexes
Timeline
20162024

Study locations (1)

Collaborators

Zogenix, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02655198 on ClinicalTrials.gov

Other trials for Epilepsy syndrome

Additional recruiting or active studies for the same condition.

See all trials for Epilepsy syndrome

← Back to all trials